Cancer

Events

Partner Content

Welcome to the 2nd Tumor Myeloid-Directed Therapies Summit

Identify, Validate, & Clinically Develop Novel Targets to Modulate Myeloid Cells & Overcome Solid Tumor Barriers

News

Biliary tract cancer drug granted orphan drug designation in...

The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation.

News

Sugemalimab plus chemo boosts lung cancer survival, trial re...

Lung cancer drug sugemalimab has delivered positive results following a phase 3 trial.

News

Clinical trial begins of lung cancer immunotherapeutic

Cancer Research UK’s Centre for Drug Development, working with the Ludwig Institute for Cancer Research and Vaccitech, has begun a phase I/IIa clinical trial of a new lung cancer vaccine.

News

Scotland backs AstraZeneca drug as first-line treatment for ...

Scotland has approved AstraZeneca’s Tagrisso (osimertinib) as a monotherapy for the for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung ca

Patients